Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination)
Trials
(efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination)
Recent Studies (post-2010) (efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination)
9,156187552731244

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonopoulou, S; Chini, M; Demopoulos, CA; Fragopoulou, E; Gargalianos, P; Lazanas, MC; Mangafas, N; Papakonstantinou, VD; Tsogas, N; Tsoupras, AB1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination

ArticleYear
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:8

    Topics: Adenine; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Deoxycytidine; Drug Combinations; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Male; Organophosphonates; Oxazines; Platelet Activating Factor; Viral Load

2012